Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / ORD SHS
-
Total 13F shares
-
1,579,237
-
Share change
-
+106,264
-
Total reported value
-
$21,194,000
-
Price per share
-
$13.42
-
Number of holders
-
15
-
Value change
-
+$1,408,417
-
Number of buys
-
7
-
Number of sells
-
7
Institutional Holders of NEURODERM LTD - ORD SHS as of Q1 2015
As of 31 Mar 2015,
NEURODERM LTD - ORD SHS was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,579,237 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP LLC, PERCEPTIVE ADVISORS LLC, BAKER BROS. ADVISORS LP, Longwood Capital Partners LLC, Alyeska Investment Group, L.P., Geduld E E, OPPENHEIMER & CO INC, GOLDMAN SACHS GROUP INC, MORGAN STANLEY, and TURNER INVESTMENTS, L.P..
This page lists
15
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.